AURALGAN Trademark

Trademark Overview


On Wednesday, April 26, 2023, a trademark application was filed for AURALGAN with the United States Patent and Trademark Office. The USPTO has given the AURALGAN trademark a serial number of 97908361. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, March 28, 2024. This trademark is owned by IPL Therapeutics LLC. The AURALGAN trademark is filed in the Pharmaceutical Products category with the following description:

Ear medication, namely, ear drops
auralgan

General Information


Serial Number97908361
Word MarkAURALGAN
Filing DateWednesday, April 26, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, March 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesEar medication, namely, ear drops

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes052, 051, 005, 018, 006, 044, 046
Class Status Code6 - Active
Class Status DateWednesday, May 24, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIPL Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCommerce City, CO 80022

Trademark Events


Event DateEvent Description
Thursday, March 28, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 28, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 28, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 24, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 24, 2024NON-FINAL ACTION E-MAILED
Wednesday, January 24, 2024NON-FINAL ACTION WRITTEN
Tuesday, January 23, 2024ASSIGNED TO EXAMINER
Wednesday, May 24, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 1, 2023NEW APPLICATION ENTERED

Related Keywords


auralgan drops namely medication